These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1052290)

  • 21. Defining peritoneal dialysis adequacy: Kt/Vurea revisited.
    Zhe XW; Shan YS; Cheng L; Tian XK; Wang T
    Ren Fail; 2007; 29(3):347-52. PubMed ID: 17497450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutritional and metabolic response to catabolic stress in uremia.
    Grodstein GP; Blumenkrantz MJ; Kopple JD
    Am J Clin Nutr; 1980 Jul; 33(7):1411-6. PubMed ID: 7395769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables.
    Recker RR; Saville PD
    J Lab Clin Med; 1971 Sep; 78(3):380-8. PubMed ID: 5092859
    [No Abstract]   [Full Text] [Related]  

  • 24. The analysis of concentration dependence of uremic lesions in clinical studies.
    Sargent JA; Gotch FA
    Kidney Int Suppl; 1975 Jan; (2):35-44. PubMed ID: 1057691
    [No Abstract]   [Full Text] [Related]  

  • 25. Factors in the dialysis regimen which contribute to alterations in the abnormalities of uremia.
    Lowrie EG; Steinberg SM; Galen MA; Gagneux SA; Lazarus JM; Gottlieb MN; Merrill JP
    Kidney Int; 1976 Nov; 10(5):409-22. PubMed ID: 1003730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determinants of small solute clearance in hemodialysis.
    Huang Z; Clark WR; Gao D
    Semin Dial; 2005; 18(1):30-5. PubMed ID: 15663761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the relative efficacy of CAPD and hemodialysis in the control of solute concentration.
    Hiatt MP; Pyle WK; Moncrief JW; Popovich RP
    Artif Organs; 1980 Feb; 4(1):37-43. PubMed ID: 7369893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study.
    Sargent JA
    Kidney Int Suppl; 1983 Apr; (13):S19-25. PubMed ID: 6345894
    [No Abstract]   [Full Text] [Related]  

  • 29. Prescription criteria in peritoneal dialysis.
    Gotch FA
    Perit Dial Int; 1994; 14 Suppl 3():S83-7. PubMed ID: 7948283
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved urea clearance raises the BUN in continuous peritoneal dialysis.
    Baltzan MA; Shoker AA; Baltzan RB; Pylypchuk GB
    Clin Nephrol; 1996 Mar; 45(3):183-7. PubMed ID: 8706360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
    Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
    Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Guanidinosuccinic acid and uremia. 1. Clinical studies].
    Dobbelstein H; Edel HH; Schmidt M; Schubert G; Weinzierl M
    Klin Wochenschr; 1971 Mar; 49(6):348-57. PubMed ID: 4929965
    [No Abstract]   [Full Text] [Related]  

  • 33. Nitrogen balance during intermittent dialysis therapy of uremia.
    Borah MF; Schoenfeld PY; Gotch FA; Sargent JA; Wolfsen M; Humphreys MH
    Kidney Int; 1978 Nov; 14(5):491-500. PubMed ID: 750694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hemodynamic effects during sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for uremic patients with brain hemorrhage: a crossover study.
    Wu VC; Huang TM; Shiao CC; Lai CF; Tsai PR; Wang WJ; Huang HY; Wang KC; Ko WJ; Wu KD;
    J Neurosurg; 2013 Nov; 119(5):1288-95. PubMed ID: 23706048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prescription of peritoneal dialysis.
    Tzamaloukas AH; Raj DS; Onime A; Servilla KS; Vanderjagt DJ; Murata GH
    Semin Dial; 2008; 21(3):250-7. PubMed ID: 18248525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Estimation of the dialysis time based on a simplified algorithm for urea kinetics].
    Pietrzyk JA
    Przegl Lek; 1992; 49(5):145-50. PubMed ID: 1438916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphate mass removal during hemodialysis: a comparison between eKT/V-matched conventional and extended dialysis.
    Sampaio MS; Ruzany F; Dorigo DM; Suassuna JH
    Am J Nephrol; 2012; 36(2):121-6. PubMed ID: 22776782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein catabolic factors in patients on renal replacement therapy.
    Bergström J
    Blood Purif; 1985; 3(4):215-36. PubMed ID: 3914307
    [No Abstract]   [Full Text] [Related]  

  • 39. Renal versus continuous versus intermittent therapies for removal of uremic toxins.
    Clark WR; Henderson LW
    Kidney Int Suppl; 2001 Feb; 78():S298-303. PubMed ID: 11169030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities].
    Maduell F
    Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.